Literature DB >> 902415

Combined Shewhart-cusum control chart for improved quality control in clinical chemistry.

J O Westgard, T Groth, T Aronsson, C H de Verdier.   

Abstract

We describe the adaptation of the decision limit cumulative sum method (cusum) to internal quality control in clinical chemistry. With the decision limit method, the cusum is interpreted against a numerical limit, rather than by use of a V-mask. The method can be readily implemented in computerized quality-control systems or manually on controls charts. We emphasize the manual application here and demonstrate how the technique can be implemented on existing Shewhart or Levey-Jennings control charts. This permits both cusum and Shewhart control rules to be used simultaneously on a single control chart and also minimizes the data calculations necessary for the cusum method. Computer simulation studies are used to determine the performance characteristics of several different cusum rules, alone and in combination with a Shewhart rule. These studies indicate that improvements in existing quality-control systems should be possible by addition of this simple cusum method and by use of a combined Shewhart-cusum control chart. This should be particularly advantageous when introducing the cusum method in laboratories with manual quality-control systems.

Mesh:

Year:  1977        PMID: 902415

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Application of intrawell testing of RCRA groundwater monitoring data when no upgradient well exists.

Authors:  C J Chou; R F O'Brien; D B Barnett
Journal:  Environ Monit Assess       Date:  2001-09       Impact factor: 2.513

2.  Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle.

Authors:  Richard W Browne; Michael S Bloom; Enrique F Schisterman; Kathy Hovey; Maurizio Trevisan; Chengqing Wu; Aiyi Liu; Jean Wactawski-Wende
Journal:  Biomarkers       Date:  2008-03       Impact factor: 2.658

3.  Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.

Authors:  Toon Van Gorp; Isabelle Cadron; Anneleen Daemen; Bart De Moor; Etienne Waelkens; Ignace Vergote
Journal:  Proteome Sci       Date:  2012-06-13       Impact factor: 2.480

Review 4.  Quality Assurance in Clinical Chemistry: A Touch of Statistics and A Lot of Common Sense.

Authors:  Elvar Theodorsson
Journal:  J Med Biochem       Date:  2016-05-09       Impact factor: 3.402

Review 5.  Guidance for laboratories performing molecular pathology for cancer patients.

Authors:  Ian A Cree; Zandra Deans; Marjolijn J L Ligtenberg; Nicola Normanno; Anders Edsjö; Etienne Rouleau; Francesc Solé; Erik Thunnissen; Wim Timens; Ed Schuuring; Elisabeth Dequeker; Samuel Murray; Manfred Dietel; Patricia Groenen; J Han Van Krieken
Journal:  J Clin Pathol       Date:  2014-07-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.